ClinicalTrials.Veeva

Menu

Non-invasive Measurement of Neonatal Central and Peripheral Hemodynamics (NInHeDyNeo)

V

Vilnius University

Status

Completed

Conditions

Pre-Term
Neonatal Infection

Treatments

Device: Ultrasound Cardiac Output Monitor (USCOM 1A)

Study type

Observational

Funder types

Other

Identifiers

NCT04200807
NCPKV-2017

Details and patient eligibility

About

Non-invasively neonatal cardiac output can be measured by multiple methods, but the gold standard still remains conventional echocardiography. It is accurate, but needs a long training for new users to assess cardiac function. Continuous-wave Doppler ultrasound monitor USCOM is a relatively new monitor which can perform faster and less complex cardiac function measurement, also it is easier for the operator to get trained. The aim of the study is to assess the level of agreement between cardiac output measured with conventional echocardiography and with USCOM, to present normal ranges for neonates of different gestational age and to look for early signs of hemodynamic changes during sepsis.

Enrollment

163 patients

Sex

All

Ages

26 to 44 weeks old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • newborns of any gestational age
  • parental consent acquired

Exclusion criteria

  • congenital malformations
  • hemodynamic instability in control group
  • any respiratory support in control group
  • infection in control group

Trial design

163 participants in 3 patient groups

Healthy preterm neonate
Description:
Neonate 26 weeks to 36 weeks + 6 days of gestation, without congenital heart defects and/or hemodynamically significant fetal circulation, any respiratory therapy, nor need of supplemental oxygen. Subjects had no clinically and laboratory-identified infections.
Treatment:
Device: Ultrasound Cardiac Output Monitor (USCOM 1A)
Healthy term neonate
Description:
Neonate from 37 weeks of gestation, without congenital heart defects and/or hemodynamically significant fetal circulation, any respiratory therapy, nor need of supplemental oxygen. Subjects had no clinically and laboratory-identified infections.
Treatment:
Device: Ultrasound Cardiac Output Monitor (USCOM 1A)
Sick neonate
Description:
Neonate of any gestation, without congenital heart defects, with clinically and laboratory-identified infection.
Treatment:
Device: Ultrasound Cardiac Output Monitor (USCOM 1A)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems